Get ready for the 'post-COVID syndrome'

The Economist’s health policy editor speaks to patients, clinicians and researchers about the long term influence of the COVID era.

Arutz Sheva Staff ,

COVID-19 vaccine
COVID-19 vaccine
iStock

The arrival of vaccines to tame COVID-19 now seems within reach, but the disease will continue to shape lives long after the pandemic.

The Economist’s health policy editor Natasha Loder speaks to patients, doctors and researchers about the symptoms that make up “long COVID”, the latest findings about its causes—and how to treat it.



top